Matrine Suppresses Osteosarcoma Lung Metastasis by Targeting the PI3K/AKT Signaling Pathway to Induce Mitochondrial Dysfunction
5 affiliations
- 1Department of Pharmacy, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan 316000, China
- 2Department of Orthopedics, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan 316000, China; [email protected] (X.L.); [email protected] (H.L.); [email protected] (X.X.); [email protected] (Y.Y.)
- 3Medical Research Center, Zhoushan Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Zhoushan 316000, China
- 4School of Medicine, Ningbo University, Ningbo 315000, China
- 5Department of Orthopedics, Shaoxing People’s Hospital, No. 123 Baiyutan Road, Yuecheng District, Shaoxing 312000, China
Abstract
Objective: Osteosarcoma, the most common primary bone malignancy in children and adolescents, frequently metastasizes to the lung, with a five-year survival rate of about 20% after lung metastasis. This study assessed whether matrine suppresses osteosarcoma lung metastasis by inducing mitochondrial dysfunction through inhibition of the PI3K/AKT pathway. Methods: Using 143B, U2OS, and MG63 cells, we assessed proliferation, colony formation, and invasion; examined mitochondrial ultrastructure, membrane potential, and reactive oxygen species (ROS); and measured PI3K/AKT phosphorylation and mitochondrial dynamics and apoptosis-related proteins by Western blotting. Direct binding of matrine to PI3K was verified by molecular docking and surface plasmon resonance (SPR). Rescue experiments used the PI3K agonist 740 Y-P, and efficacy was tested in subcutaneous xenograft and tail vein lung metastasis models. Results: Matrine inhibited the proliferation, colony formation, and invasion of 143B, U2OS, and MG63 cells in a concentration-dependent manner, with 143B cells being the most sensitive, and in vivo, it suppressed tumor growth and lung metastasis without obvious organ toxicity. Mechanistically, matrine caused mitochondrial swelling, cristae rupture, membrane potential loss, and ROS accumulation; upregulated FIS1, Bax, and cytochrome c; and downregulated Mfn1 and Mfn2. It directly bound to PI3K and inhibited PI3K/AKT phosphorylation. The PI3K agonist 740 Y-P only partially reversed these effects, indicating partial dependence on the PI3K/AKT pathway. Conclusions: Matrine suppresses osteosarcoma lung metastasis by targeting the PI3K/AKT pathway to induce mitochondrial dysfunction and may be a useful therapeutic agent.
Related
- Epstein-Barr virus-encoded microRNA-BART17-5p suppresses cell proliferation and metastasis by targeting CERK
- Isoquercitrin ameliorates chondrocyte dysfunction in osteoarthritis by targeting AKT1-mediated mitochondrial dynamics regulation
- Theranostic peptide-selenium hydrogel targeting NETs-mitochondrial dysfunction-pyroptosis axis for chronic diabetic wound repair.
- Cardiolipin-Specific Targeting of Melittin via Arg22 in Lipid Membranes: A Natural Toxin-Based Strategy for Treating Mitochondrial Dysfunction in Aging and Disease.
- Spontaneous Pneumothorax During Stereotactic Body Radiotherapy for Pulmonary Metastasis From Osteosarcoma: A Case Report and Literature Review
BibTeX
@article{jiang2026matrine,
title = {{Matrine Suppresses Osteosarcoma Lung Metastasis by Targeting the PI3K/AKT Signaling Pathway to Induce Mitochondrial Dysfunction}},
author = {Chanyi Jiang and Xiankun Liu and Yijun Yu and Hongming Lin and Xiaochun Xiong and Yinghao Yu and Songou Zhang},
journal = {Cancers},
year = {2026},
month = oct,
doi = {10.3390/cancers18203381},
url = {https://www.mdpi.com/2072-6694/18/20/3381},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Matrine Suppresses Osteosarcoma Lung Metastasis by Targeting the PI3K/AKT Signaling Pathway to Induce Mitochondrial Dysfunction
AU - Chanyi Jiang
AU - Xiankun Liu
AU - Yijun Yu
AU - Hongming Lin
AU - Xiaochun Xiong
AU - Yinghao Yu
AU - Songou Zhang
PY - 2026
DA - 2026/10/01
JO - Cancers
DO - 10.3390/cancers18203381
UR - https://www.mdpi.com/2072-6694/18/20/3381
AB - Objective: Osteosarcoma, the most common primary bone malignancy in children and adolescents, frequently metastasizes to the lung, with a five-year survival rate of about 20% after lung metastasis. This study assessed whether matrine suppresses osteosarcoma lung metastasis by inducing mitochondrial dysfunction through inhibition of the PI3K/AKT pathway. Methods: Using 143B, U2OS, and MG63 cells, we assessed proliferation, colony formation, and invasion; examined mitochondrial ultrastructure, membrane potential, and reactive oxygen species (ROS); and measured PI3K/AKT phosphorylation and mitochondrial dynamics and apoptosis-related proteins by Western blotting. Direct binding of matrine to PI3K was verified by molecular docking and surface plasmon resonance (SPR). Rescue experiments used the PI3K agonist 740 Y-P, and efficacy was tested in subcutaneous xenograft and tail vein lung metastasis models. Results: Matrine inhibited the proliferation, colony formation, and invasion of 143B, U2OS, and MG63 cells in a concentration-dependent manner, with 143B cells being the most sensitive, and in vivo, it suppressed tumor growth and lung metastasis without obvious organ toxicity. Mechanistically, matrine caused mitochondrial swelling, cristae rupture, membrane potential loss, and ROS accumulation; upregulated FIS1, Bax, and cytochrome c; and downregulated Mfn1 and Mfn2. It directly bound to PI3K and inhibited PI3K/AKT phosphorylation. The PI3K agonist 740 Y-P only partially reversed these effects, indicating partial dependence on the PI3K/AKT pathway. Conclusions: Matrine suppresses osteosarcoma lung metastasis by targeting the PI3K/AKT pathway to induce mitochondrial dysfunction and may be a useful therapeutic agent.
SN - 2072-6694
ER -